112 related articles for article (PubMed ID: 15036913)
1. Degenerate recognition and response of human CD4+ Th cell clones: implications for basic and applied immunology.
Nishimura Y; Chen YZ; Uemura Y; Tanaka Y; Tsukamoto H; Kanai T; Yokomizo H; Yun C; Matsuoka T; Irie A; Matsushita S
Mol Immunol; 2004 Feb; 40(14-15):1089-94. PubMed ID: 15036913
[TBL] [Abstract][Full Text] [Related]
2. Response of a human T cell clone to a large panel of altered peptide ligands carrying single residue substitutions in an antigenic peptide: characterization and frequencies of TCR agonism and TCR antagonism with or without partial activation.
Chen YZ; Matsushita S; Nishimura Y
J Immunol; 1996 Nov; 157(9):3783-90. PubMed ID: 8892606
[TBL] [Abstract][Full Text] [Related]
3. Modification of human T-cell responses by altered peptide ligands: a new approach to antigen-specific modification.
Nishimura Y; Chen YZ; Kanai T; Yokomizo H; Matsuoka T; Matsushita S
Intern Med; 1998 Oct; 37(10):804-17. PubMed ID: 9840700
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein.
Ausubel LJ; Bieganowska KD; Hafler DA
Cell Immunol; 1999 Apr; 193(1):99-107. PubMed ID: 10202117
[TBL] [Abstract][Full Text] [Related]
5. Induction of anergy in human T helper 0 cells by stimulation with altered T cell antigen receptor ligands.
Tsitoura DC; Holter W; Cerwenka A; Gelder CM; Lamb JR
J Immunol; 1996 Apr; 156(8):2801-8. PubMed ID: 8609399
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific immunomodulation via altered peptide ligands.
Bielekova B; Martin R
J Mol Med (Berl); 2001 Oct; 79(10):552-65. PubMed ID: 11692152
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal recognition of a T cell epitope of the major dog allergen Can f 1 by human T cells.
Juntunen R; Liukko A; Taivainen A; Närvänen A; Durand G; Kauppinen A; Nieminen A; Rytkönen-Nissinen M; Saarelainen S; Maillère B; Virtanen T; Kinnunen T
Mol Immunol; 2009 Oct; 46(16):3320-7. PubMed ID: 19700193
[TBL] [Abstract][Full Text] [Related]
8. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
Li R; Li X; Li Z
Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
[TBL] [Abstract][Full Text] [Related]
9. Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.
Piesche M; Hildebrandt Y; Zettl F; Chapuy B; Schmitz M; Wulf G; Trümper L; Schroers R
Hum Immunol; 2007 Jul; 68(7):572-6. PubMed ID: 17584578
[TBL] [Abstract][Full Text] [Related]
10. Potential of an altered peptide ligand of lipocalin allergen Bos d 2 for peptide immunotherapy.
Kinnunen T; Jutila K; Kwok WW; Rytkönen-Nissinen M; Immonen A; Saarelainen S; Närvänen A; Taivainen A; Virtanen T
J Allergy Clin Immunol; 2007 Apr; 119(4):965-72. PubMed ID: 17335888
[TBL] [Abstract][Full Text] [Related]
11. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.
Piesche M; Hildebrandt Y; Chapuy B; Wulf GG; Trümper L; Schroers R
Vaccine; 2009 Jul; 27(34):4718-23. PubMed ID: 19446593
[TBL] [Abstract][Full Text] [Related]
13. Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis.
Caccamo N; Meraviglia S; La Mendola C; Bosze S; Hudecz F; Ivanyi J; Dieli F; Salerno A
Eur J Immunol; 2004 Aug; 34(8):2220-9. PubMed ID: 15259019
[TBL] [Abstract][Full Text] [Related]
14. Modification of peptide interaction with MHC creates TCR partial agonists.
Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
[TBL] [Abstract][Full Text] [Related]
15. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
Cheng YJ; Zhou Q; Li ZG
Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor crossreactivity as a general property of T cell recognition.
Wucherpfennig KW
Mol Immunol; 2004 Feb; 40(14-15):1009-17. PubMed ID: 15036904
[TBL] [Abstract][Full Text] [Related]
18. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
Hemmer B; Vergelli M; Gran B; Ling N; Conlon P; Pinilla C; Houghten R; McFarland HF; Martin R
J Immunol; 1998 Apr; 160(8):3631-6. PubMed ID: 9558061
[TBL] [Abstract][Full Text] [Related]
19. Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.
Hillman GG; Kallinteris NL; Lu X; Wang Y; Wright JL; Li Y; Wu S; Forman JD; Gulfo JV; Humphreys RE; Xu M
Cancer Treat Rev; 2004 May; 30(3):281-90. PubMed ID: 15059651
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor.
Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI
Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
